Articles by Renaissance Capital
Tableau and Marketo push May US IPO pricings to 22, marking busiest month since November 2007
5/17/2013, 12:06 pm from Renaissance Capital in News Headlines, IPOs
Tableau ( DATA
), which sells a data visualization platform, and Marketo ( MKTO ), a provider of
marketing automation software, priced their IPOs last night,
pushing total IPO pricings in... Read >>
Tableau Software prices upsized IPO above the revised range at $31
5/16/2013, 6:10 pm from Renaissance Capital in News Headlines, IPOs
Tableau Software, which provides interactive data visualization
software, raised $254 million by offering 8.2 million shares at
$31, above the revised range of $28 to $30. The company... Read >>
Marketo prices IPO at $13, at high end of the range
5/16/2013, 5:56 pm from Renaissance Capital in News Headlines, IPOs
Marketo, which provides on-demand marketing software to SMBs and
enterprises, raised $79 million by offering 6.1 million shares at
$13, at the high end of the $11-$13 range.Marketo will list on... Read >>
PTC Therapeutics files for a $85 million IPO following failed IPO attempt in 2006
5/16/2013, 5:39 pm from Renaissance Capital in News Headlines, IPOs
PTC Therapeutics, which develops orally administered,
proprietary small-molecule drugs that target post-transcriptional
control processes, filed on Thursday with the SEC to raise up to
$85... Read >>
William Lyon Homes prices IPO above the range at $25
5/16/2013, 8:45 am from Renaissance Capital in News Headlines, IPOs
William Lyon Homes, which is leading regional homebuilder in CA,
AZ, NV and CO, raised $218 million by offering 8.7 million shares
at $25, above the range of $22 to $24. William Lyon Homes... Read >>
UBIC prices IPO at $8.38, within the range
5/16/2013, 8:36 am from Renaissance Capital in News Headlines, IPOs
UBIC, a provider of Asian-language software-based eDiscovery
services, raised $9 million by offering 1.1 million shares at
$8.38, within the range of $7.50 to $9.50. UBIC plans to list on
the... Read >>
Israeli therapeutics company Kamada sets terms for $60 million U.S. IPO
5/15/2013, 11:51 pm from Renaissance Capital in News Headlines, IPOs
Kamada, which produces plasma-derived protein therapeutics,
announced terms for its IPO on Wednesday. The Ness Ziona,
Israel-based company plans to raise $60 million by offering 5.6
million... Read >>
Ambit Biosciences prices IPO at $8
5/15/2013, 6:48 pm from Renaissance Capital in News Headlines, IPOs
Ambit Biosciences, which is developing small molecule
therapeutics for the treatment of acute myeloid leukemia, raised
$65 million by offering 8.1 million shares at $8. Ambit Biosciences
plans... Read >>
Tableau Software increases price range for IPO, new deal size is $209 million
5/15/2013, 1:24 pm from Renaissance Capital in News Headlines, IPOs
Tableau Software, which provides interactive data visualization
software, raised the proposed deal size for its upcoming IPO on
Wednesday. The Seattle, WA-based company now plans to raise... Read >>
Ambit Biosciences revises terms for IPO, maintains $65 million deal size
5/15/2013, 8:51 am from Renaissance Capital in News Headlines, IPOs
Ambit Biosciences, which is developing small molecule
therapeutics for the treatment of acute myeloid leukemia, revised
the terms for its upcoming IPO on Wednesday, but maintained the
total... Read >>